News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Eduard Viladesau, Managing Director de HIPRA Biotech Services
#BIOSPAIN2025 | HIPRA Biotech Services: strengthening Europe’s strategic autonomy in biotechnology
BioSpain
Eduard Viladesau, Managing Director of HIPRA Biotech Services, Gold Sponsor of BIOSPAIN 2025,…
Avencia Sánchez Mejías, CEO de Integra Therapeutics
Integra Therapeutics secures €10.7 million investment round to advance development of FiCAT gene writing platform and preclinical validation of CAR-T therapies
Healthcare · Advanced therapies · Financing
The investment combines funds from new investors like the EIC Fund (European Commission) and CDTI…
 Talking Science in Summer: Bionet is making bioprocessing easier to understand
Talking Science in Summer: Bionet is making bioprocessing easier to understand
Access to innovation
Bioprocessing is full of complex terms and concepts that can be difficult to digest. This summer,…
Natac transforma más de 9.000 toneladas de biomasa en ingredientes de alto valor
Natac transformed over 9,000 tons of biomass into high-value ingredients
Circular economy · Corporate
This is reflected in its 2024 Sustainability Report, which reviews the company's main ESG…
 La revolución de la microbiota
The microbiota revolution
Healthcare
The study of the microbiota has gone from a focus limited to digestion to become a pillar of…
José María Giménez Arnau, Chief Scientific & Medical Officer de ESTEVE
#BIOSPAIN2025 | “It represents an opportunity to share knowledge, explore new avenues of collaboration, and connect with key stakeholders in the sector”
BioSpain
José María Giménez Arnau, Chief Scientific & Medical Officer at ESTEVE, Gold Sponsor of…
Biorreactores de HIPRA
SPEEDCELL, the new European project led by HIPRA, aims to reduce vaccine and biologics development to 100 days in emergency situations
Healthcare · Access to innovation · Innovative drugs
With a duration of 4 years, this EU4Health program project aims to contribute to strengthening…
Olivier Corminboeuf y Blandine Guimet
Nuage Therapeutics welcomes Olivier Corminboeuf and Blandine Guimet to their Leadership Team
Corporate
The biotech company Nuage Therapeutics, based at the Barcelona Science Park, continues to grow with…
Mujer mirando a la pantalla de un monitor
ProtoAD: a new tool to anticipate the suitability of predictions
Access to innovation
ProtoQSAR has launched ProtoAD, a new tool integrated into the ProtoPRED platform, developed in…